EFFICACY OF UPADACITINIB FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE BY DISEASE DURATION: A POST HOC ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES

Ryan C. Ungaro  1     Jean-Frédéric Colombel  1     Edouard J. Louis  2     Marc Ferrante  3     Takayuki Matsumoto  4     Chirag Doshi  5     Ana Paula Machado De Lacerda  5     Valencia Remple  5     Elena Dubcenco  5     Samuel Anyanwu  5     Andrew Garrison  5     Remo Panaccione  6    
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 University Hospital CHU of Liège, Liège, Belgium
3 University Hospitals Leuven, Leuven, Belgium
4 Iwate Medical University, Morioka, Japan
5 AbbVie Inc., North Chicago, United States
6 University of Calgary, Calgary, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing